ViMRT
}  
 
Home   
< Docs   

 SARS_CoV_2 mutation literature information.


  A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
 PMID: 35222380       2022       Frontiers in immunology
Introduction: They also found that the mutation always occurs mutually with mutation 1059C>T-(T85I).
Table: T85I


  Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk.
 PMID: 35075180       2022       Scientific reports
Table: T85I


  Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
 PMID: 34848355       2022       Infection, genetics and evolution
Table: T85I


  An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern.
 PMID: 34272947       2022       Clinical infectious diseases
Result: Of the 93 substitutions that were present in 2020, 61 were no longer present during March 2021 (Figure 5C), and only 8 were present in >5% of samples during March 2021 (NSP2:T85I, NSP12:P323L, S:L5F, S:D614G, NS3aQ57H, NS8:S24L, N:R203K, and N:G204R).
Result: The most common amino acid substitutions across lineages were S:D614G, NSP12:P323L, NSP2:


  Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates.
 PMID: 34740719       2022       Virus research
Table: T85I


  The Algerian Chapter of SARS-CoV-2 Pandemic: An Evolutionary, Genetic, and Epidemiological Prospect.
 PMID: 34452390       2021       Viruses
Discussion: This included T85I in the nsp2 gene, P423L in the nsp12 gene, D614G in the S gene, and Q57H in the ORF3a gene.


  Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
 PMID: 34147651       2021       Infection, genetics and evolution
Abstract: Among the 7 highly recurring (percentage frequency>=10%) mutations (Nsp2:T85I, Nsp6:L37F, Nsp12:P323L, Spike:D614G, ORF3a:Q57H, N protein:R203K and N protein:G204R), N protein:R203K and N protein: G204R are co-occurring (dependent) mutations.
Abstract: Further, the occurrence of ORF3a: PMID: 34428777       2021       Nature
Introduction: Non-spike mutations widely shared by B.1.526-E484K and B.1.526-S477N isolates include: T85I in ORF1a-nsp2; L438P in ORF1a-nsp4, a 9-base pair (bp) deletion (Delta106-108) in ORF1a-nsp6; P323L in ORF1b-nsp12; Q88H in ORF1b-nsp13; Q57H in ORF3a; and P199L and M234I in the N<


  Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021.
 PMID: 34356077       2021       Genes
Result: The NSP2_T85I mutation was reported at 40.20% and 59.59% in SARS-CoV-2 genome sequences isolated from Africa and South America, respectively.


  Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.
 PMID: 34157472       2021       Computers in biology and medicine
Table: T85I



Browser Board

 Co-occurred Entities




   Filtrator